RU2602739C2 - Производное пиразола и его применение в медицинских целях - Google Patents

Производное пиразола и его применение в медицинских целях Download PDF

Info

Publication number
RU2602739C2
RU2602739C2 RU2014149181/15A RU2014149181A RU2602739C2 RU 2602739 C2 RU2602739 C2 RU 2602739C2 RU 2014149181/15 A RU2014149181/15 A RU 2014149181/15A RU 2014149181 A RU2014149181 A RU 2014149181A RU 2602739 C2 RU2602739 C2 RU 2602739C2
Authority
RU
Russia
Prior art keywords
constipation
group
compound
administration
administered
Prior art date
Application number
RU2014149181/15A
Other languages
English (en)
Russian (ru)
Other versions
RU2014149181A (ru
Inventor
Масаюки ИЗАДЗИ
Масааки ТАКЕМУРА
Хидетоси ИСАВА
Юкихико ХОТЕИ
Итару МИЯСИТА
Original Assignee
Киссеи Фармасьютикал Ко., Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Киссеи Фармасьютикал Ко., Лтд. filed Critical Киссеи Фармасьютикал Ко., Лтд.
Publication of RU2014149181A publication Critical patent/RU2014149181A/ru
Application granted granted Critical
Publication of RU2602739C2 publication Critical patent/RU2602739C2/ru

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
RU2014149181/15A 2012-05-07 2013-05-02 Производное пиразола и его применение в медицинских целях RU2602739C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2012105847 2012-05-07
JP2012-105847 2012-05-07
PCT/JP2013/062755 WO2013168671A1 (ja) 2012-05-07 2013-05-02 ピラゾール誘導体及びその医薬用途

Publications (2)

Publication Number Publication Date
RU2014149181A RU2014149181A (ru) 2016-06-27
RU2602739C2 true RU2602739C2 (ru) 2016-11-20

Family

ID=49550709

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2014149181/15A RU2602739C2 (ru) 2012-05-07 2013-05-02 Производное пиразола и его применение в медицинских целях

Country Status (15)

Country Link
US (2) US9273085B2 (enExample)
EP (1) EP2848254B1 (enExample)
JP (2) JP5663699B2 (enExample)
KR (1) KR101868991B1 (enExample)
CN (1) CN104284665B (enExample)
AU (1) AU2013258566B2 (enExample)
BR (1) BR112014027841B1 (enExample)
CA (1) CA2872002C (enExample)
DK (1) DK2848254T3 (enExample)
ES (1) ES2601127T3 (enExample)
MX (1) MX359988B (enExample)
PL (1) PL2848254T3 (enExample)
PT (1) PT2848254T (enExample)
RU (1) RU2602739C2 (enExample)
WO (1) WO2013168671A1 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2586931T3 (es) 2010-11-04 2016-10-19 Albireo Ab Inhibidores de IBAT para el tratamiento de enfermedades hepáticas
EP2848254B1 (en) * 2012-05-07 2016-08-03 Kissei Pharmaceutical Co., Ltd. Pyrazole derivative and use thereof for medical purposes
WO2014119787A1 (ja) 2013-02-04 2014-08-07 大正製薬株式会社 便秘症の予防又は治療薬
CN106573033A (zh) * 2014-06-25 2017-04-19 Ea制药株式会社 固体制剂及其稳定化方法
CN106659726A (zh) 2014-06-25 2017-05-10 Ea制药株式会社 固体制剂及其着色防止或着色减少方法
US11596644B2 (en) 2018-03-28 2023-03-07 Avolynt Method for treating post-prandial hypoglycemia
JP7391048B2 (ja) 2018-06-05 2023-12-04 アルビレオ・アクチボラグ ベンゾチア（ジ）アゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用
MX2020013839A (es) 2018-06-20 2021-03-25 Albireo Ab Formulacion farmaceutica de odevixibat.
US11801226B2 (en) 2018-06-20 2023-10-31 Albireo Ab Pharmaceutical formulation of odevixibat
US11007142B2 (en) 2018-08-09 2021-05-18 Albireo Ab Oral cholestyramine formulation and use thereof
US11549878B2 (en) 2018-08-09 2023-01-10 Albireo Ab In vitro method for determining the adsorbing capacity of an insoluble adsorbant
TWI835997B (zh) 2019-02-06 2024-03-21 瑞典商艾爾比瑞歐公司 苯并噻氮呯化合物及其用作膽酸調節劑之用途
RS63899B1 (sr) 2019-02-06 2023-02-28 Albireo Ab Benzotiadiazepinska jedinjenja i njihova upotreba kao modulatora žučnih kiselina
EP4069359B1 (en) 2019-12-04 2024-01-03 Albireo AB Benzothia(di)azepine compounds and their use as bile acid modulators
CA3158181A1 (en) 2019-12-04 2021-06-10 Albireo Ab Benzothia(di)azepine compounds and their use as bile acid modulators
US11014898B1 (en) 2020-12-04 2021-05-25 Albireo Ab Benzothiazepine compounds and their use as bile acid modulators
JP7665620B2 (ja) 2019-12-04 2025-04-21 アルビレオ・アクチボラグ ベンゾチアジアゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用
BR112022010505A2 (pt) 2019-12-04 2022-09-06 Albireo Ab Compostos de benzotia(di)azepina e seu uso como moduladores do ácido biliar
CA3186857A1 (en) 2020-08-03 2022-02-10 Per-Goran Gillberg Benzothia(di)azepine compounds and their use as bile acid modulators
AU2021379076A1 (en) 2020-11-12 2023-06-08 Albireo Ab Odevixibat for treating progressive familial intrahepatic cholestasis (pfic)
AU2021390172A1 (en) 2020-12-04 2023-06-22 Albireo Ab Benzothia(di)azepine compounds and their use as bile acid modulators
TW202313579A (zh) 2021-06-03 2023-04-01 瑞典商艾爾比瑞歐公司 苯并噻(二)氮呯(benzothia(di)azepine)化合物及其作為膽酸調節劑之用途

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009084531A1 (ja) * 2007-12-27 2009-07-09 Kissei Pharmaceutical Co., Ltd. ピラゾール誘導体のモノセバシン酸塩
WO2009128421A1 (ja) * 2008-04-16 2009-10-22 キッセイ薬品工業株式会社 ピラゾール誘導体の１／２フマル酸塩
RU2437888C2 (ru) * 2006-04-26 2011-12-27 Дженентек, Инк. Ингибиторы фосфоинозитид-3-киназы и содержащие их фармацевтические композиции

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004137245A (ja) 2002-08-23 2004-05-13 Kissei Pharmaceut Co Ltd ピラゾール誘導体、それを含有する医薬組成物、その医薬用途及びその製造中間体
JPWO2011002001A1 (ja) * 2009-07-01 2012-12-13 キッセイ薬品工業株式会社 ピラゾール誘導体とビグアナイド薬との組み合わせ医薬
AR087701A1 (es) 2011-08-31 2014-04-09 Japan Tobacco Inc Derivados de pirazol con actividad inhibidora de sglt1
EP2848254B1 (en) * 2012-05-07 2016-08-03 Kissei Pharmaceutical Co., Ltd. Pyrazole derivative and use thereof for medical purposes

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2437888C2 (ru) * 2006-04-26 2011-12-27 Дженентек, Инк. Ингибиторы фосфоинозитид-3-киназы и содержащие их фармацевтические композиции
WO2009084531A1 (ja) * 2007-12-27 2009-07-09 Kissei Pharmaceutical Co., Ltd. ピラゾール誘導体のモノセバシン酸塩
WO2009128421A1 (ja) * 2008-04-16 2009-10-22 キッセイ薬品工業株式会社 ピラゾール誘導体の１／２フマル酸塩

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ОКОРОКОВ А.Н., Диагностика болезней внутренних органов, Москва, Медицинская литература, 2000, с. 219-225, 264-266;THOMPSON WG et al, Functional bowel disorders and functional abdominal pain.Gut. 1999 Sep; N 45 Suppl 2: c. II43-7. PMID:10457044. *

Also Published As

Publication number Publication date
US9273085B2 (en) 2016-03-01
BR112014027841B1 (pt) 2022-08-09
CN104284665A (zh) 2015-01-14
PL2848254T3 (pl) 2017-03-31
PT2848254T (pt) 2016-10-05
EP2848254A1 (en) 2015-03-18
EP2848254B1 (en) 2016-08-03
AU2013258566B2 (en) 2017-03-16
CN104284665B (zh) 2016-11-16
BR112014027841A2 (pt) 2017-06-27
US20160129031A1 (en) 2016-05-12
JP6105546B2 (ja) 2017-03-29
WO2013168671A1 (ja) 2013-11-14
MX359988B (es) 2018-10-18
CA2872002C (en) 2019-01-15
CA2872002A1 (en) 2013-11-14
US20150141631A1 (en) 2015-05-21
KR101868991B1 (ko) 2018-06-19
BR112014027841A8 (pt) 2021-09-28
EP2848254A4 (en) 2015-07-15
KR20150013671A (ko) 2015-02-05
ES2601127T3 (es) 2017-02-14
US9694027B2 (en) 2017-07-04
JPWO2013168671A1 (ja) 2016-01-07
MX2014013696A (es) 2015-02-05
AU2013258566A1 (en) 2014-11-27
HK1204773A1 (en) 2015-12-04
RU2014149181A (ru) 2016-06-27
DK2848254T3 (en) 2016-10-31
JP2015083580A (ja) 2015-04-30
JP5663699B2 (ja) 2015-02-04

Similar Documents

Publication Publication Date Title
DK2848254T3 (en) PYRAZOLD DERIVATIVE AND ITS USE FOR MEDICAL PURPOSES
JP7312169B2 (ja) 遺伝性てんかん性障害の処置に使用するガナキソロン
CN114929209A (zh) 肌萎缩侧索硬化的治疗
JP6790140B2 (ja) 下痢を治療するための製品及び方法
US20040147509A1 (en) Method of treating functional bowel disorders
KR20240043778A (ko) 장시간-작용하는 glp1/글루카곤 수용체 작용제를 위한 용량 용법
US11390620B2 (en) Polymorphic forms of metopimazine
CN106456620A (zh) 胃轻瘫用5‑ht4受体激动剂
HK1204773B (en) Pyrazole derivative and use thereof for medical purposes
CN114272381A (zh) M型胆碱能受体激动剂的应用和缓解烦渴症状的药物
US20110269792A1 (en) Compositions useful for treating irritable bowel syndrome
HK1213205B (en) Product and method for treating diarrhea